GlassScriptPhysician profile
Brittany Guthrie Mitchell
NPI 1881255891
$12,343.67
in general payments reported to CMS, 2019-2025
35 companies · $2,538 in 2025
The $2,538 reported for 2025 was more than what 95% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,919 · 2022: $2,141 · 2023: $2,971 · 2024: $1,774 · 2025: $2,538.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,283.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,914.15 | 2021-2025 | |
| Alkermes, INC. | $1,632.33 | 2021-2025 | Aristada, Lybalvi, Vivitrol |
| Neurocrine Biosciences, INC. | $1,009.40 | 2021-2025 | Ingrezza |
| Otsuka America Pharmaceutical, INC. | $802.16 | 2021-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Janssen Pharmaceuticals, INC | $741.93 | 2021-2025 | Spravato, Invega Sustenna, Invega Trinza |
| Validus Pharmaceuticals LLC | $716.01 | 2021-2024 | Equetro |
| Lundbeck LLC | $680.26 | 2021-2025 | Rexulti, Abilify Maintena |
| Corium, LLC | $455.04 | 2021-2025 | Azstarys, Adlarity |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $445.48 | 2021-2025 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $389.12 | 2021-2025 | Austedo Xr, Austedo, Austedo Xr |
| Axsome Therapeutics, INC. | $385.74 | 2022-2025 | Auvelity, Sunosi |
| Takeda Pharmaceuticals U.S.A., INC. | $382.79 | 2021-2025 | Trintellix |
| Indivior INC. | $358.85 | 2021-2025 | Sublocade, Perseris |
| Bausch Health US, LLC | $319.30 | 2021-2025 | Wellbutrin, Aplenzin |
| Tris Pharma INC | $300.77 | 2021-2025 | Dyanavel Xr |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $267.73 | 2021-2025 | Fanapt, Hetlioz |
| Acadia Pharmaceuticals INC | $217.55 | 2021-2024 | Nuplazid |
| Sunovion Pharmaceuticals INC. | $213.76 | 2021-2022 | |
| Almatica Pharma LLC | $202.92 | 2021-2025 | Loreev Xr, Sertraline Hcl |
| Noven Therapeutics, LLC | $128.66 | 2022-2024 | Xelstrym, Secuado |
| Idorsia Pharmaceuticals US INC | $122.41 | 2022-2024 | Quviviq |
| Eisai INC. | $107.36 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $88.28 | 2022-2023 | Belsomra |
| Jazz Pharmaceuticals INC. | $83.03 | 2021-2022 | |
| Ironshore Pharmaceuticals INC. | $78.73 | 2023-2024 | Jornay Pm |
| Avanir Pharmaceuticals, INC. | $65.56 | 2021-2022 | |
| Biogen, INC. | $46.92 | 2025 | Zurzuvae |
| Supernus Pharmaceuticals, INC. | $43.33 | 2022-2025 | Qelbree |
| E.R. Squibb & Sons, L.L.C. | $42.46 | 2025 | Cobenfy |
| Avion Pharmaceuticals | $22.84 | 2023 | Methylphenidate Hydrochloride |
| Braeburn INC. | $19.18 | 2024 | Brixadi |
| Harmony Biosciences LLC | $18.83 | 2025 | |
| Collegium Pharmaceutical, INC. | $14.72 | 2025 | Jornay Pm |
| Currax Pharmaceuticals LLC | $13.76 | 2021 | |
| Neos Therapeutics, LP | $12.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.